Cerity Partners
RCKT icon

Cerity Partners’s Rocket Pharmaceuticals RCKT Stock Holding History

Cerity Partners’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$314K Buy
91,825
+12,851
+16% +$42.7K ﹤0.01% 2758
2026
Q1 		$283K Buy
78,974
+56,182
+246% +$223K ﹤0.01% 2652
2025
Q4 		$80K Buy
22,792
+9,605
+73% +$32.9K ﹤0.01% 2776
2025
Q3 		$43K Buy
+13,187
New +$41.5K ﹤0.01% 2707

Other funds holding RCKT

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Cerity Partners's RCKT Position: Q2 2026 in Review

Cerity Partners increased its Rocket Pharmaceuticals (RCKT) stake by 16% in Q2 2026, buying an estimated $42.7K and bringing the position to 91,825 shares worth $314K. The position accounts for ﹤0.01% of the portfolio, ranked #2758.

Cerity Partners first reported a position in RCKT in Q3 2025 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Cerity Partners held 91,825 shares of Rocket Pharmaceuticals worth $314K as of Q2 2026.
  • Cerity Partners bought 12,851 Rocket Pharmaceuticals shares in Q2 2026, an estimated $42.7K.
  • Rocket Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2758 holding.
  • Cerity Partners first reported a position in Rocket Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.